Norman David Eansor
CIK: 0001270905
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Marker Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Nov 17, 2025MRKR
Marker Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
84.4K shares- - Nov 17, 2025MRKR
Marker Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
137.3K shares- - Feb 12, 2025MRKR
Marker Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
30K shares-
1-3 of 3 transactions
About Eansor Norman David
Eansor Norman David (SEC CIK 0001270905) files insider reports with the SEC as Director of Marker Therapeutics, Inc. (MRKR).
Signal8 holds 2 ownership filings by Eansor Norman David, all Form 4s, filed between Feb 14, 2025 and Nov 19, 2025. Those filings report 3 transactions, from Feb 12, 2025 to Nov 17, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Eansor Norman David's filings is in HOUSTON, TX.
Recent filings by Eansor Norman David
Other insiders filing for Marker Therapeutics, Inc. (MRKR)
- Knobil Katharine, Director
- ELMS STEVE, Director
- Corzo Kathryn Penkus, Director
- Vera Juan, President and CEO
- New Enterprise Associates 16, L.P., 10% Owner